Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Could Patient Stratification Help Lilly Finally Unlock An Alzheimer’s Breakthrough?
Tau Status Stratification Unique To Lilly Trial
Jun 20 2022
•
By
Andrew McConaghie
Lilly's TRAILBLAZER 2 will be the last of the three competitor trials to read out, in mid-2023. • Source: Michael Vi / Shutterstock.com
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip